Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 24 04:00PM ET
5.52
Dollar change
+0.14
Percentage change
2.60
%
Index- P/E- EPS (ttm)-0.17 Insider Own6.49% Shs Outstand34.38M Perf Week1.47%
Market Cap189.78M Forward P/E200.73 EPS next Y0.03 Insider Trans-3.07% Shs Float32.15M Perf Month-3.83%
Income-6.18M PEG- EPS next Q-0.08 Inst Own50.92% Short Float2.39% Perf Quarter-1.95%
Sales32.55M P/S5.83 EPS this Y27.50% Inst Trans51.23% Short Ratio1.63 Perf Half Y44.13%
Book/sh0.72 P/B7.68 EPS next Y123.71% ROA-21.76% Short Interest0.77M Perf Year52.49%
Cash/sh0.72 P/C7.63 EPS next 5Y- ROE-36.69% 52W Range2.51 - 7.17 Perf YTD-14.29%
Dividend Est.- P/FCF- EPS past 5Y62.04% ROI-19.28% 52W High-23.01% Beta1.51
Dividend TTM- Quick Ratio2.91 Sales past 5Y57.09% Gross Margin71.23% 52W Low119.85% ATR (14)0.38
Dividend Ex-Date- Current Ratio3.22 EPS Y/Y TTM39.01% Oper. Margin-19.07% RSI (14)52.50 Volatility3.96% 7.22%
Employees185 Debt/Eq0.33 Sales Y/Y TTM69.17% Profit Margin-19.00% Recom1.00 Target Price9.25
Option/ShortYes / Yes LT Debt/Eq0.30 EPS Q/Q90.41% Payout- Rel Volume0.30 Prev Close5.38
Sales Surprise21.93% EPS Surprise57.08% Sales Q/Q153.73% EarningsMar 10 AMC Avg Volume471.71K Price5.52
SMA208.65% SMA50-2.51% SMA20016.26% Trades Volume142,460 Change2.60%
Date Action Analyst Rating Change Price Target Change
Jul-31-24Initiated Craig Hallum Buy $7
May-20-24Initiated Lake Street Buy $7
Dec-15-23Initiated H.C. Wainwright Buy $6.50
Nov-11-20Upgrade ROTH Capital Neutral → Buy $5 → $7
May-27-20Initiated Dougherty & Company Buy $8.50
Oct-02-17Initiated H.C. Wainwright Buy $12
Mar-11-25 01:12PM
03:03AM
Mar-10-25 05:15PM
04:05PM
Mar-07-25 07:06AM
04:05PM Loading…
Mar-03-25 04:05PM
Dec-05-24 07:30AM
Dec-04-24 04:05PM
Nov-07-24 02:22AM
Nov-06-24 06:00PM
04:05PM
Nov-05-24 08:07AM
Oct-31-24 04:05PM
Oct-30-24 04:05PM
Oct-18-24 05:01PM
05:08PM Loading…
Oct-09-24 05:08PM
04:05PM
Sep-12-24 08:30AM
Sep-05-24 04:15PM
Aug-06-24 04:05PM
Jul-30-24 04:05PM
Jul-27-24 07:40AM
Jul-26-24 06:05PM
Jul-08-24 08:30AM
Jun-11-24 10:50AM
Jun-05-24 05:58PM
Jun-01-24 02:42AM
May-17-24 07:01PM
May-10-24 04:03PM
01:01PM
01:16PM Loading…
May-09-24 01:16PM
May-08-24 04:05PM
May-06-24 01:19PM
08:30AM
May-01-24 05:21PM
Mar-28-24 04:05PM
Mar-18-24 11:00AM
Mar-08-24 10:15AM
Mar-07-24 06:00PM
04:05PM
Mar-01-24 08:00AM
Feb-29-24 04:05PM
Jan-19-24 04:05PM
Jan-17-24 08:05AM
08:00AM
Dec-20-23 08:50AM
Dec-12-23 07:00AM
Dec-01-23 10:00AM
Nov-20-23 04:16PM
Nov-08-23 11:47AM
Nov-07-23 04:05PM
Nov-06-23 08:30AM
Nov-02-23 10:08AM
Oct-31-23 04:05PM
Aug-29-23 04:05PM
Aug-28-23 12:38PM
Aug-25-23 07:00AM
Aug-24-23 07:33PM
04:15PM
04:05PM
Aug-21-23 04:05PM
Aug-09-23 05:30PM
04:05PM
Aug-02-23 04:05PM
Jul-05-23 10:50AM
Jul-03-23 08:30AM
Jun-14-23 04:05PM
May-22-23 09:55AM
May-10-23 06:05PM
May-09-23 07:05PM
May-05-23 07:45AM
May-03-23 04:05PM
Apr-10-23 08:30AM
Mar-16-23 05:30AM
Mar-15-23 08:30AM
Mar-14-23 11:11AM
Mar-13-23 09:45AM
08:30AM
Mar-07-23 10:12AM
Mar-06-23 04:05PM
Feb-06-23 04:05PM
Feb-01-23 04:25PM
Jan-30-23 04:05PM
Jan-17-23 04:05PM
Jan-12-23 08:30AM
Jan-10-23 04:17PM
Dec-07-22 05:00PM
Dec-05-22 08:30AM
Nov-21-22 03:04PM
Nov-10-22 05:55PM
04:05PM
Nov-09-22 05:25PM
Nov-03-22 04:05PM
Oct-05-22 04:30PM
Sep-07-22 08:30AM
Aug-30-22 08:30AM
Aug-03-22 06:35PM
04:05PM
Jul-28-22 10:03AM
Jul-27-22 04:15PM
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRK THOMAS FDirectorMar 13 '25Buy5.007,40037,000255,933Mar 14 09:00 PM
Mitchell MicahChief Commercial OfficerMar 14 '25Sale5.1648,000247,565140,572Mar 14 05:36 PM
MICAH MITCHELLOfficerMar 14 '25Proposed Sale5.1648,000247,565Mar 14 05:24 PM
Kovelman HarryChief Medical OfficerMar 12 '25Sale5.5030,000165,01897,973Mar 13 04:41 PM
Micah MitchellOfficerMar 13 '25Proposed Sale5.221,2836,697Mar 13 04:31 PM
David HenryOfficerMar 13 '25Proposed Sale5.222,01910,539Mar 13 04:30 PM
Harry KovelmanOfficerMar 13 '25Proposed Sale5.221,4967,809Mar 13 04:28 PM
HARRY KOVELMANOfficerMar 12 '25Proposed Sale5.5030,000165,015Mar 12 04:59 PM
GUDONIS PAUL RChief Executive OfficerFeb 13 '25Option Exercise0.05694331,014,963Feb 18 04:33 PM
Mitchell MicahChief Commercial OfficerJun 09 '24Option Exercise0.001,7170185,815Jan 24 05:09 PM
HENRY DAVID AChief Financial OfficerJun 09 '24Option Exercise0.003,0120381,375Jan 24 05:05 PM
Kovelman HarryChief Medical OfficerJun 09 '24Option Exercise0.001,2350124,549Jan 24 05:02 PM
GUDONIS PAUL RChief Executive OfficerJun 09 '24Option Exercise0.006,02401,014,269Jan 24 04:58 PM
Harry KovelmanOfficerNov 04 '24Proposed Sale3.70121448Nov 04 03:19 PM
Harry KovelmanOfficerOct 03 '24Proposed Sale3.86121467Oct 03 12:54 PM
Kovelman HarryChief Medical OfficerSep 05 '24Sale3.766,70025,183123,556Sep 09 04:04 PM
Kovelman HarryChief Medical OfficerSep 03 '24Sale4.012,0298,140130,395Sep 05 08:27 AM
Harry KovelmanOfficerSep 04 '24Proposed Sale3.89139541Sep 04 06:26 PM
Harry KovelmanOfficerSep 03 '24Proposed Sale4.0018,50074,000Sep 03 05:55 PM
Harry KovelmanOfficerAug 05 '24Proposed Sale3.96128507Aug 05 11:53 AM
KIRK THOMAS FDirectorMay 29 '24Buy3.5050,000175,000236,499May 31 05:43 PM
Kovelman HarryChief Medical OfficerMay 15 '24Sale3.6935,426130,83998,009May 17 04:57 PM